本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Atea Pharmaceuticals, Inc.

5.12
-0.2100-3.94%
盤後5.120.00000.00%19:52 EDT
成交量:32.01萬
成交額:165.19萬
市值:4.08億
市盈率:-2.64
高:5.40
開:5.33
低:5.08
收:5.33
52周最高:6.45
52周最低:2.46
股本:7,967.21萬
流通股本:5,950.97萬
量比:0.57
換手率:0.54%
股息:- -
股息率:- -
每股收益(TTM):-1.9430
每股收益(LYR):-1.9430
淨資產收益率:-44.34%
總資產收益率:-28.75%
市淨率:1.48
市盈率(LYR):-2.64

資料載入中...

2024/02/07

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/28

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/10/02

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

重要事件披露

Form 8-K - Current report
2023/06/22

重要事件披露

Form 8-K - Current report
2023/05/22

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/05/08

重要事件披露

8-K - Current report
2023/05/08

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/02/28

重要事件披露

8-K - Current report
2023/02/28

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]